Dr Matthew Williams Consultant Profile
Dr Matthew Williams trained in Birmingham, before moving to London where he trained at the Hammersmith Hospital. He completed his clinical oncology training in London, followed by a PhD with the Advanced Computation Lab at CRUK/UCL. He was appointed as a consultant at Imperial College Healthcare NHS Trust in February 2012, where he specialises in neuro-oncology and is joint MDT lead for neuro-oncology.
He is an Honorary Senior Fellow at Imperial College, where he leads the Computational Oncology Group. He sits on the NCRI Brain Tumour clinical trials group, and has a particular interest in studies looking at novel approaches to improving current treatments in neuro-oncology.
Dr Williams chairs the neuro-oncology MDT at The London Clinic, and has worked to make The London Clinic the only site in the UK that offers the INTRAGO-II trial of intra-operative radiotherapy in newly diagnosed patients with GBM.
Areas of expertise
- Glioblastoma
- Optune (Tumour Treating Fields)
- Neuro-oncology
- Brain tumour chemotherapy
- Brain tumour radiotherapy
- Brain metastases
- Recurrent Glioma
- Stereotactic radiotherapy
- Stereotactic Radiosurgery (SRS)
- Radiotherapy-chemotherapy combinations for glioma
- Metabolic approaches to modulating radiotherapy response in glioma
- Computational Oncology